Total Payments
$108,386
2024 Payments
$45,260
Companies
63
Transactions
902
Medicare Patients
394
Medicare Billing
$82,157
Payment Breakdown by Category
Other$60,565 (55.9%)
Food & Beverage$21,792 (20.1%)
Consulting$19,106 (17.6%)
Travel$6,867 (6.3%)
Education$55.13 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,515 | 24 | 40.1% |
| Food and Beverage | $21,792 | 820 | 20.1% |
| Consulting Fee | $19,106 | 15 | 17.6% |
| Honoraria | $17,050 | 6 | 15.7% |
| Travel and Lodging | $6,867 | 31 | 6.3% |
| Education | $55.13 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NEUROPACE, INC. | $27,383 | 84 | $0 (2024) |
| SK Life Science, Inc. | $18,248 | 34 | $0 (2024) |
| LivaNova USA, Inc. | $17,658 | 52 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $12,452 | 28 | $0 (2024) |
| Greenwich Biosciences, Inc. | $9,788 | 15 | $0 (2021) |
| Neurelis, Inc. | $8,371 | 30 | $0 (2024) |
| UCB, Inc. | $2,483 | 69 | $0 (2024) |
| ABBVIE INC. | $1,840 | 91 | $0 (2024) |
| Eisai Inc. | $928.67 | 30 | $0 (2023) |
| CATALYST PHARMACEUTICALS, INC. | $750.32 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,260 | 242 | NEUROPACE, INC. ($21,159) |
| 2023 | $22,588 | 222 | LivaNova USA, Inc. ($10,722) |
| 2022 | $9,803 | 349 | LivaNova USA, Inc. ($3,266) |
| 2021 | $11,726 | 20 | SK Life Science, Inc. ($9,183) |
| 2020 | $10,725 | 22 | SK Life Science, Inc. ($8,378) |
| 2019 | $6,299 | 22 | Greenwich Biosciences, Inc. ($5,650) |
| 2018 | $321.83 | 7 | Eisai Inc. ($179.48) |
| 2017 | $1,662 | 18 | NEUROPACE, INC. ($1,132) |
All Payment Transactions
902 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: Epilepsy | ||||||
| 12/18/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Travel and Lodging | In-kind items and services | $610.42 | General |
| Category: Epilepsy | ||||||
| 12/18/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $169.01 | General |
| Category: Epilepsy | ||||||
| 12/18/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Travel and Lodging | In-kind items and services | $163.19 | General |
| Category: Epilepsy | ||||||
| 12/18/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Travel and Lodging | In-kind items and services | $156.90 | General |
| Category: Epilepsy | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Neurology | ||||||
| 12/18/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Epilepsy | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Rare Disease | ||||||
| 12/16/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Immune | ||||||
| 12/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: PAIN | ||||||
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $140.35 | General |
| Category: Neurology | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $138.81 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $54.59 | General |
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $199.67 | General |
| 12/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $41.00 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/08/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/08/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 12/07/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $77.27 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 124 | 198 | $59,110 | $27,840 |
| 2022 | 6 | 194 | 260 | $103,685 | $45,879 |
| 2021 | 2 | 31 | 37 | $7,196 | $2,483 |
| 2020 | 3 | 45 | 57 | $16,167 | $5,955 |
Total Patients
394
Total Services
552
Medicare Billing
$82,157
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 133 | $36,410 | $18,072 | 49.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $19,890 | $8,675 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $2,810 | $1,093 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 74 | $22,200 | $10,601 | 47.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 26 | 26 | $23,608 | $10,040 | 42.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 52 | 52 | $22,152 | $9,219 | 41.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 22 | 23 | $17,595 | $7,567 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 72 | $16,128 | $7,481 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $2,002 | $970.67 | 48.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 26 | $4,911 | $1,581 | 32.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 11 | 11 | $2,285 | $901.67 | 39.5% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 12 | 21 | $8,991 | $3,622 | 40.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 20 | 20 | $4,154 | $1,680 | 40.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 16 | $3,022 | $653.64 | 21.6% |
About Dr. Edward Maa, MD
Dr. Edward Maa, MD is a Neurological Surgery healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053426643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Maa, MD has received a total of $108,386 in payments from pharmaceutical and medical device companies, with $45,260 received in 2024. These payments were reported across 902 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,515).
As a Medicare-enrolled provider, Maa has provided services to 394 Medicare beneficiaries, totaling 552 services with total Medicare billing of $82,157. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Other Specialties Epilepsy Unit
- Location Denver, CO
- Active Since 08/21/2006
- Last Updated 09/08/2025
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1053426643
Products in Payments
- RNS Neurostimulator Kit (Device) $25,783
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $13,896
- EPIDIOLEX (Drug) $12,424
- Epidiolex (Drug) $9,788
- XCOPRI (Drug) $9,281
- VALTOCO (Drug) $8,371
- Cenobamate (Drug) $8,342
- VNS Therapy SenTiva Model 1000 Generator (Device) $3,266
- RNS System (Device) $1,600
- Briviact (Drug) $1,009
- Fycompa (Drug) $840.10
- BOTOX (Biological) $829.53
- FYCOMPA (Drug) $713.82
- UBRELVY (Drug) $701.54
- Fintepla (Drug) $657.60
- NURTEC ODT (Drug) $651.76
- PANZYGA (Biological) $572.71
- ZEPOSIA (Drug) $572.71
- VNS Therapy (Device) $570.48
- KESIMPTA (Drug) $504.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurological Surgery Doctors in Denver
Dr. Sean Markey, M.d, M.D
Neurological Surgery — Payments: $176,808
Neurological Surgery $176,808
Jens-Peter Witt, Md, MD
Neurological Surgery — Payments: $102,011
Neurological Surgery $102,011
Dr. Todd Crawford, M.d, M.D
Neurological Surgery — Payments: $4,924
Neurological Surgery $4,924
Dr. Donny Melton, M.d, M.D
Neurological Surgery — Payments: $4,706
Neurological Surgery $4,706
Dr. Peter Lennarson, Md, MD
Neurological Surgery — Payments: $3,823
Neurological Surgery $3,823
Dr. Edin Nevzati, Md, MD
Neurological Surgery — Payments: $3,694
Neurological Surgery $3,694